Advertisement

Topics

Advanced Cell Technology Incorporated Company Profile

19:16 EST 22nd November 2017 | BioPortfolio

Advanced Cell Technology Announces License of its Cloning Patents to Immerge Biotherapeutics, INC., a Joint Venture Between Novartis Pharma Ag and Biotransplant, Inc. Worcester, MA, April 16, 2002—Advanced Cell Technology, Inc. (ACT) announced today the license of animal cloning technology to Immerge BioTherapeutics, Inc. of Charlestown, MA. The worldwide nonexclusive license will cover Immerge’s work in the development of genetically modified pigs for potential use in xenotransplantation (the use of animal organs to address human health issues). “We are excited to participate in a program that offers such hope for thousands of people,” said Michael D. West, Ph.D., President and C.E.O. of ACT. “Xenotransplantation may one day offer life-saving technology for people with kidney, lung, and heart failure and other degenerative diseases.” Immerge was formed as a joint venture between Novartis Pharma AG (NYSE:NVS) and BioTransplant, Incorporated (Nasdaq: BTRN) in September, 2000. Since that time, the company has reached two important milestones – the development of inbred miniature swine that are incapable of transmitting porcine retrovirus that can infect human cells and the development of the first knock-out cloned miniature swine. Both of these milestones have moved xenotransplantation closer to the clinic. Immerge has also previously announced a collaboration in pig nuclear transfer cloning with Infigen, Inc. “Cloning plays an important role in the further development of xenotransplantation and in the Immerge program,” said Julia Greenstein, Ph.D. President and C.E.O. of Immerge. “ACT’s technology will be an important enhancement to the intellectual property supporting our work.” The patents licensed to Immerge include U.S. Patent Nos. 6,235,970, 6,235,969, 6,215,041, and 5,945,577, the latter being the subject of an interference proceeding with Geron Corporation. Immerge will have the right to contract with third parties to manufacture product using ACT’s cloning technology. The need to find new sources for donor organs is a critical one, and the demand is growing each day. According to the United Network for Organ Sharing (UNOS), there are currently more than 79,000 people on the U.S. transplant waiting list and a new name is added to the list every 14 minutes. An equal number of prospective transplant patients never make the list because of the strict criteria needed to ensure that precious organs go to those candidates that are most likely to be successful recipients. Xenotransplantation offers the best hope for these people. Advanced Cell Technology is a biotechnology company focused on the discovery and commercialization of cloning technology for application in medicine and agriculture.

Location

1201 Harbor Bay Parkway
Suite 120
Alameda
94502
United States of America

Contact

Phone: 310.481.5124
Fax: 510.748.4950
Email: mwest@advancedcell.com


News Articles [2116 Associated News Articles listed on BioPortfolio]

Advanced Cell Technology:Gary Rabin. Applying Stem Cell-Based Technologies to Create Patient-Specific Therapies

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Gary Rabin, CEO of Advanced Cell Technology

Cell therapy technology and innovation centre - expressions of interest

Technology Strategy Board is seeking expressions of interest from organisations that might lead or form part of a new technology and innovation centre focused on cell therapy. The centre will be based...

[News] NICE guidance on cabozantinib for previously treated advanced renal cell carcinoma

On August 9, 2017, the National Institute for Health and Care Excellence (NICE) published technology appraisal guidance1 recommending cabozantinib, within its marketing authorisation, as an option for...

Opdivo in Combination with Yervo Demonstrates Improved Overall Survival for Advanced Renal Cell Carcinoma

A Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with previously untreated advanced or metastatic renal cell […] The post Opdivo in Combination with Yervo Demon...

Researchers Develop Single Cell Level Sorting Technology Using Sound Waves

New cell manipulation technology enables highly accurate isolation of rare cell populations in complex biological samples

Bio-Techne enters Genomics market with $250M acquisition of Advanced Cell Diagnostics

Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to $75M...

Advanced Cell Diagnostics raises $22 million USD in latest round of financing

Advanced Cell Diagnostics (ACD) have raised a further $22 million in Series C equity financing, with proceeds to be used to accelerate their entry into the research and clinical diagnostics

EU approves ceritinib in ALK-positive advanced non-small cell lung cancer

The European Commission has approved expanding the use of ceritinib to include the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumours are anaplastic lymph...

PubMed Articles [5000 Associated PubMed Articles listed on BioPortfolio]

Application of single-cell technology in cancer research.

In this review, we have outlined the application of single-cell technology in cancer research. Single-cell technology has made encouraging progress in recent years and now provides the means to detect...

Lessons from single-cell transcriptome analysis of oxygen-sensing cells.

The advent of single-cell RNA-sequencing (RNA-Seq) technology has enabled transcriptome profiling of individual cells. Comprehensive gene expression analysis at the single-cell level has proven to be ...

Stem Cell Smart Technology, where are we now and how far we have to go?

Approximately eight million people in the United States have peripheral arterial disease, which increases exponentially with age. There have been a plethora of available treatments including surgery, ...

Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation.

To establish a prognostic signature for locally advanced tongue squamous cell carcinoma (TSCC) patients treated with surgery.

The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.

The usefulness of a recently developed advanced lung cancer inflammation index (ALI) has been reported in advanced non-small-cell lung cancer (NSCLC) and small-cell lung cancer. However, no previous s...

Clinical Trials [10293 Associated Clinical Trials listed on BioPortfolio]

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL ...

Companies [2701 Associated Companies listed on BioPortfolio]

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...

3D Biotek

Founded in April 2007, 3D Biotek LLC is a biotechnology company located in New Jersey, USA. Using its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Tech...

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem c...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Advanced Cell Technology Incorporated" on BioPortfolio

We have published hundreds of Advanced Cell Technology Incorporated news stories on BioPortfolio along with dozens of Advanced Cell Technology Incorporated Clinical Trials and PubMed Articles about Advanced Cell Technology Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cell Technology Incorporated Companies in our database. You can also find out about relevant Advanced Cell Technology Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cloning
Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...


Corporate Database Quicklinks



Searches Linking to this Company Record